Exane Asset Management Bristol Myers Squibb CO Transaction History

Exane Asset Management

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 27, 2020	SELL	$54.82 - $64.09 $658,443 - $769,784	-12,011 Closed	0 $0
Q1 2020 Apr 22, 2020	SELL	$46.4 - $67.43 $908,419 - $1.32 Million	-19,578 Reduced 61.98%	12,011 $669 Million
Q4 2019 Feb 03, 2020	SELL	$49.21 - $64.19 $8.43 Million - $11 Million	-171,268 Reduced 84.43%	31,589 $2.03 Million
Q3 2019 Oct 24, 2019	SELL	$42.77 - $50.71 $1.39 Million - $1.65 Million	-32,613 Reduced 13.85%	202,857 $10.3 Million
Q2 2019 Aug 05, 2019	SELL	$44.62 - $49.34 $3.5 Million - $3.87 Million	-78,425 Reduced 24.98%	235,470 $0
Q1 2019 May 07, 2019	BUY	$45.12 - $53.8 $11.5 Million - $13.7 Million	255,502 Added 437.56%	313,895 $0
Q4 2018 Feb 05, 2019	SELL	$48.76 - $63.23 $13 Million - $16.9 Million	-266,748 Reduced 82.04%	58,393 $3.04 Million
Q3 2018 Nov 16, 2018	SELL	$55.19 - $62.25 $2.8 Million - $3.16 Million	-50,696 Reduced 13.49%	325,141 $0
Q2 2018 Sep 06, 2018	SELL	$50.53 - $62.98 $7.36 Million - $9.17 Million	-145,669 Reduced 27.93%	375,837 $0
Q1 2018 Apr 30, 2018	BUY	$59.92 - $68.98 $8.28 Million - $9.53 Million	138,180 Added 36.05%	521,506 $0
Q4 2017 Feb 08, 2018	SELL	$59.94 - $65.35 $5.42 Million - $5.91 Million	-90,435 Reduced 19.09%	383,326 $0
Q3 2017 Oct 13, 2017	BUY	$55.23 - $63.74 $26.2 Million - $30.2 Million	473,761	473,761 $30.2 Billion

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Exane Asset Management, based on Form 13F filings with the SEC.

Stay updated on Exane Asset Management with notifications on news.